UNC Lineberger Comprehensive Cancer Center

UNC Lineberger Comprehensive Cancer Center is more than a center for treatment and research. It’s a mission — that together, we will work toward a deep, transformative understanding of cancer, from the molecular level to the societal, and translate that knowledge into improved treatments and patient outcomes. It’s a promise that, with your help, we will push scientific discovery and create novel therapies.

UNC Lineberger stands preeminent among institutions conducting cancer research and delivering compassionate care. The National Cancer Institute has designated only 51 centers as comprehensive, and of those UNC Lineberger is one of fewer than five currently rated “exceptional.” We are the only public comprehensive cancer center in North Carolina, serving all of its citizens through the game-changing cancer research we conduct and the critical, life-saving care we provide.

UNC Lineberger Comprehensive Cancer Center Funding Priorities

Explore Stories

Tom, Wilson, and Nancy Chewning stand in their house.
Donor

Venture Philanthropy

Investing in nascent research ideas may unlock future cures

A triple negative breast cancer cell line stained for endothelial cells and blood vessel content. Using immunofluorescence, the researchers showed that blood vessels in the cell line are leaky.
Donor

Supporting Innovative Cancer Treatments

Donor gives $25 million to establish UNC Lineberger Center for Triple Negative Breast Cancer.

Rich Preyer and Marilyn Jacobs Preyer
Donor

Reducing Breast Cancer Disparities And Barriers To Care

Rich Preyer and Marilyn Jacobs Preyer have donated $1 million to support UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study

Donor

Grateful patient and husband establish breast cancer research fund

Ensuring access to the most advanced care

Health

Deepening Our Understanding

Using next generation sequencing to better understand COVID-19

Health

Precision Cancer Treatments

"It's an exciting approach; we hit the tumor hard with little toxicity, leaving room for other therapy."